Primech Holdings Ltd. Ordinary Shares (PMEC) Dividend History

Primech Holdings Ltd. is a company involved in the provision of industrial and commercial cleaning solutions, equipment, and maintenance services. It specializes in offering sanitation and hygienic products, along with associated support services, to various sectors including healthcare, hospitality, and industrial industries.

Dividend History

Primech Holdings Ltd. Ordinary Shares currently does not pay dividends

Company News

  • Primech AI showcased its HYTRON LITE bathroom cleaning robot at a facilities management event in Singapore, highlighting its compact design and advanced AI capabilities. The event showcased the growing importance of robotic solutions in addressing labor challenges and enhancing operational efficiency in the facilities management sector.

    GlobeNewswire Inc.
  • U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 15 points on Thursday. The Dow traded up 0.06% to 39,785.29 while the NASDAQ fell 0.13% to 16,383.85. The S&P 500 also rose, gaining, 0.10% to 5,253.70. Check This Out: Jim Cramer Likes Crown Castle, But Can't Recommend Archer Aviation: It Has 'No Earnings Power'   Leading and Lagging Sectors   Energy shares jumped by 1.1% on Thursday. In trading on Thursday, communication services shares fell by 0.2%.   Top Headline   Shares of MSC Industrial Direct Co., Inc. (NYSE: MSM) fell over 2% during Thursday’s session after the company reported mixed second-quarter results. MSC Industrial Direct reported second-quarter FY24 net sales decline of 2.7% Y/Y to $935.3 million, missing the consensus of $946.5 million. Adjusted EPS of $1.18, down 18.6%, beating the consensus of $1.16. MSC Industrial reiterated the outlook for FY24 ADS growth of 0%-5%, adjusted operating margin of 12% – 12.8%, and an operating cash flow conversion of more than 125%.   Equities Trading UP   Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares shot up 384% to $22.98 after the company announced it acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio. The company also announced a private placement financing of up to $185 million. Shares of Xilio Therapeutics, Inc. (NASDAQ:

    Benzinga
    Featured Companies: AVTX DTST MSM UGRO XLO
Page data last updated 07/23/2025 14:43:40 UTC